Aktie 300511 SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shanghai Xuerong Biotechnology Co.,Ltd.

Aktien

300511

CNE100002706

300511

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
3.65 CNY +1.67% Intraday Chart für Shanghai Xuerong Biotechnology Co.,Ltd. +15.14% -31.78%
25.04. Shanghai Xuerong Biotechnology Co.,Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
2023 Shanghai Xuerong Biotechnology Co.,Ltd. meldet Ergebnis für die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Approves Board Appointments
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. Approves By-Election of Directors
Shanghai Xuerong Biotechnology Co.,Ltd. Announces Final Cash Dividend Proposal for 2021
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Shanghai Xuerong Biotechnology Co.,Ltd. announced that it has received CNY 397.999996 million in funding
Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity Investment & Management Co., Ltd. agreed to acquire 5% stake in Shanghai Xuerong Biotechnology Co.,Ltd. from Yang Yongping for CNY134 million.
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shanghai Xuerong Biotechnology Co.,Ltd. Announces to Implement Final Cash Distribution Plan for 2020, Payable on 14 May 2021
Shanghai Xuerong Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2020
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Shanghai Xuerong Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2020
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Shanghai Juhui Biopharmaceutical Industrial Development Co., Ltd. entered into a share transfer agreement to acquire Shanghai Gaorong Biotechnology Co., Ltd. from Shanghai Xuerong Biotechnology Co., Ltd. and Shanghai Xuerong Edible Fungus Co., Ltd for CNY 78 million.
Shanghai Xuerong Biotechnology Co., Ltd. announced that it expects to receive CNY 2.25 billion in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300511 Aktie
  4. Nachrichten Shanghai Xuerong Biotechnology Co.,Ltd.
  5. Andere Sprachen